4//SEC Filing
Dietz Charles E 4
Accession 0001213900-22-018995
CIK 0001000683other
Filed
Apr 7, 8:00 PM ET
Accepted
Apr 8, 4:48 PM ET
Size
8.3 KB
Accession
0001213900-22-018995
Insider Transaction Report
Form 4
Dietz Charles E
Director
Transactions
- Award
Stock Option (right to buy)
2022-04-07+20,000→ 20,000 totalExercise: $0.57Exp: 2032-04-07→ Common Stock par value $0.001 (20,000 underlying) - Award
Stock Option (right to buy)
2022-04-07+20,000→ 20,000 totalExercise: $0.57Exp: 2032-04-07→ Common Stock par value $0.001 (20,000 underlying)
Footnotes (6)
- [F1]The stock option was granted under the 2016 Director Equity Incentive Plan.
- [F2]The exercise price equals the fair market value (equal to the closing price as reported on the NYSE American) of the common stock on the grant date.
- [F3]The stock option vests on the first anniversary of the grant date
- [F4]The stock option was granted under the 2016 Director Equity Incentive Plan.
- [F5]The exercise price equals the fair market value (equal to the closing selling price as reported on the NYSE American) of the common stock on the grant date.
- [F6]The stock option vests on 09/30/22.
Documents
Issuer
BLONDER TONGUE LABORATORIES INC
CIK 0001000683
Entity typeother
Related Parties
1- filerCIK 0001530204
Filing Metadata
- Form type
- 4
- Filed
- Apr 7, 8:00 PM ET
- Accepted
- Apr 8, 4:48 PM ET
- Size
- 8.3 KB